Latest Overdiagnosis Stories
ARNHEM, The Netherlands, April 16 /PRNewswire/ -- The European Association of Urology (EAU) has taken into consideration the recent scientific information on randomised screening studies on prostate cancer (SchrÃƒÂ¶der et al, NEJM 2009).
The results of two large, long-awaited studies show that prostate cancer screening does not necessarily save lives, and in some cases may lead to unneeded treatments with serious side effects.
Screening for prostate cancer can reduce deaths by 20%, according to the results of the European Randomized Study of Screening for Prostate Cancer (ERSPC) published online 1700 hours CET, today 18 March (NEJM, Online First*)
STOCKHOLM, Sweden, March 18 /PRNewswire/ -- - Attn: Healthcare Editors Screening for prostate cancer can reduce deaths by 20%, according to the results of the European Randomized Study of Screening for Prostate Cancer (ERSPC) published online 1700 hours CET 18 March (NEJM, Online First*).
Despite efforts to promote early screening, low-income men may be waiting too long for prostate cancer screening.
By H. Gilbert Welch, M.D. In a U.S. presidential campaign that promises straight talk and no gimmicks, why do both candidates champion one of medical care's most pervasive myths? The myth is that like magic, preventive medicine will simultaneously reduce costs and improve health.
REHOVOT, Israel, September 24 /PRNewswire-FirstCall/ -- BioView Ltd, from Rehovot, Israel, reported today results of its internal clinical trial of the non-invasive diagnostic test under development for early detection of lung cancer.
By WILLIAM J CATALONA Many media reports followed a federal task force's announcement this month that there is insufficient medical evidence to assess the risks and benefits of prostate cancer screening in men younger than 75 and that doctors should stop testing men over age 75.
By William J.
In a move that could lead to significant changes in medical care for older men, a national task force in the United States has recommended that doctors stop screening men aged 75 and older for prostate cancer because the search for the disease in that group is causing more harm than good.
- A volcanic mudflow.